Adalimumab for Rheumatoid Arthritis: Considerations for Reimbursement by Third-Party Payors

Author: Leo van de Putte  

Publisher: Adis International

ISSN: 1173-8790

Source: Disease Management & Health Outcomes, Vol.12, Iss.1, 2004-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract